Switzerland· 60150004
Rotarix, Suspension zum Einnehmen
A rotavirus, lebend abgeschwächt product containing rotavirus humanus vivus attenuatum (stamm: rix4414), registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Rotavirus, lebend abgeschwächt is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BH01 (rotavirus, lebend abgeschwächt), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Rotavirus, lebend abgeschwächt · ATC J07BH01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- rotavirus humanus vivus attenuatum (Stamm: RIX4414)
- Manufacturer
- GlaxoSmithKline AG
- Country
- Switzerland (CH)
- ATC code
- J07BH01
- ATC class
- Rotavirus, lebend abgeschwächt
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680601500043Tb 1.5 mlCHF 59.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BH01
Rotavirus, lebend abgeschwächt, as other registers publish it.
- NorwayRotarixGlaxoSmithKline Biologicals Services S.A
- FinlandRotarixGlaxoSmithKline Biologicals SA
- DenmarkRotarixGlaxoSmithKline Biologicals S.A.
- BelgiumRotarixGlaxoSmithKline Biologicals
- FinlandRotarixGlaxoSmithKline Biologicals SA
- PolandRotarixGlaxoSmithKline Biologicals S.A.
- PolandRotarixGlaxoSmithKline Biologicals S.A.
- DenmarkRotarixGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfd7b51e-3736-42b5-b393-5f684566e7c9 GET /v1/drugs/bfd7b51e-3736-42b5-b393-5f684566e7c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "rotavirus humanus (stamm: rix4414) 1 Mio U",
"valid_from": "2026-01-01",
"limitations": "[{\"description\":\"ROTARIX ist angezeigt für die aktive Immunisierung von Kindern ab dem Alter von 6 Wochen bis 24 Wochen zur Vorbeugung einer Rotaviren (RV)-bedingten Gastroenteritis. Es werden zwei Dosen ROTARIX (d.h. 2 Tuben zu 1.5 ml) vergütet.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2026-01-01\",\"validTo\":\"2028-12-31\"}]",
"galenic_form": "Susp oral",
"therapeutic_area": null,
"sl_inclusion_date": "2024-01-01",
"self_retention_pct": 10
}See everything about rotavirus, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.